2014 Speakers



Mark  Alles

Mark Alles
President and Chief Operating Officer, Celgene Corporation

Manny  Alvarez

Manny Alvarez
Senior Managing Editor, Health News, Fox News; Chairman, Department of Obstetrics and Gynecology, Hackensack University Medical Center

Margaret  Anderson

Margaret Anderson
Executive Director, FasterCures


Peter  Bach

Peter Bach
Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center

Annette  Bakker

Annette Bakker
President and Chief Scientific Officer, Children's Tumor Foundation

Dana  Ball

Dana Ball
Executive Director and Co-Founder, T1D Exchange; CEO, Unitio, Inc.

Anna  Barker

Anna Barker
Professor and Director, Transformative Healthcare Networks; Co-Director, Complex Adaptive Systems Network, Arizona State University

Ethan  Basch

Ethan Basch
Director, Cancer Outcomes Research Program; Associate Professor, Medicine and Public Health, UNC-Chapel Hill, Cancer Prevention and Control

Anne  Beal

Anne Beal
Chief Patient Officer, Sanofi

Sangeeta  Bhatia

Sangeeta Bhatia
Director, Laboratory for Multiscale Regenerative Technologies and Professor, Massachusetts Institute of Technology

Debra  Black

Debra Black
Co-Founder and Board Chair, Melanoma Research Alliance

B. Bonin  Bough

B. Bonin Bough
Vice President, Global Media and Consumer Engagement, Mondelez International

LaTese  Briggs

LaTese Briggs
Associate Director, Philanthropy Advisory Service, FasterCures

Martha  Brumfield

Martha Brumfield
President & CEO, Critical Path Institute

ShaAvhrée  Buckman-Garner

ShaAvhrée Buckman-Garner
Director, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Atul  Butte

Atul Butte
Chief of the Division of Systems Medicine and Associate Professor of Pediatrics, Medicine, and Computer Science, Stanford University


Pablo  Cagnoni

Pablo Cagnoni
President, Onyx Pharmaceuticals, Inc.

Darlene  Cavalier

Darlene Cavalier
Founder, SciStarter

Lynda  Chin

Lynda Chin
Department Chair, Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Francis  Collins

Francis Collins
Director, National Institutes of Health

Meryl  Comer

Meryl Comer
President, Geoffrey Beene Foundation Alzheimer's Initiative; Founder, WomenAgainstAlzheimers

Gregory  Curt

Gregory Curt
Chairman, Life Sciences Consortium, CEO Roundtable on Cancer; Executive Director, US Medical Affairs, AstraZeneca


The Honorable Diana  DeGette

The Honorable Diana DeGette
Chief Deputy Whip, U.S. House of Representatives

Angela  DeMichele

Angela DeMichele
Co-Leader, Breast Cancer Research Program, Perelman School of Medicine, University of Pennsylvania

Michelle  Dipp

Michelle Dipp
Co-Founder & CEO, OvaScience; Founder and Partner, Longwood Fund

Amy  Dockser Marcus

Amy Dockser Marcus
Staff Reporter, The Wall Street Journal

Andrea  Downing

Andrea Downing
BRCActivist, Founder, Brave Bosom

Deborah  Dunsire

Deborah Dunsire
President & CEO, FORUM Pharmaceuticals

Esther  Dyson

Esther Dyson
Founder, HICCup

Kafui  Dzirasa

Kafui Dzirasa
Assistant Professor, Department of Psychiatry and Behavioral Sciences, Center for Neuroengineering, Duke University Medical Center


Cartier  Esham

Cartier Esham
Executive Vice President, Emerging Companies, Biotechnology Industry Organization


Michael  Foley

Michael Foley
Director, Tri-Institutional Therapeutics Discovery Institute

Patricia  Furlong

Patricia Furlong
President and CEO, Parent Project Muscular Dystrophy


Ilan  Ganot

Ilan Ganot
Founder and CEO, Solid Ventures

James  Geraghty

James Geraghty
Entrepreneur-in-Residence, Third Rock Ventures

Gary  Gibbons

Gary Gibbons
Director, National Heart, Lung, and Blood Institute, National Institutes of Health

Steven  Gilman

Steven Gilman
Chief Scientific Officer and Executive Vice President, Research & Development, Cubist Pharmaceuticals Inc.

Kathy  Giusti

Kathy Giusti
Founder and Executive Chairwoman, Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium

Laurie  Glimcher

Laurie Glimcher
Dean, Weill Cornell Medical College

Michel  Goldman

Michel Goldman
Director, Innovative Medicines Initiative

Daniel  Gorfine

Daniel Gorfine
Director, Financial Markets Policy and Legal Counsel, Milken Institute

Eric  Green

Eric Green
Director, National Human Genome Research Institute, National Institutes of Health


Magali  Haas

Magali Haas
Founder and CEO, Orion Bionetworks

William  Hanlon

William Hanlon
Vice President, Head of Global Regulatory Affairs, Covance

Richard  Hodes

Richard Hodes
Director, National Institute on Aging, National Institutes of Health

Joanna  Horobin

Joanna Horobin
Chief Medical Officer, Verastem, Inc.


Louis  Jacques

Louis Jacques
Senior Vice President and Chief Clinical Officer, ADVI

Allan  Jones

Allan Jones
CEO, Allen Institute for Brain Science


Isaac  Kinde

Isaac Kinde
MD-PhD Candidate, Johns Hopkins University

Michael  Kolodziej

Michael Kolodziej
National Medical Director, Oncology Solutions, Office of the Chief Medical Officer, Aetna


Eckhard  Leifke

Eckhard Leifke
Global Head of Development, Diabetes, Sanofi

Mark  Lim

Mark Lim
Associate Director, Medical Research Innovation, FasterCures

Craig  Lipset

Craig Lipset
Head, Clinical Innovation, Worldwide Research & Development, Pfizer Inc.

Roger  Longman

Roger Longman
CEO, Real Endpoints

Thomas  Luby

Thomas Luby
Senior Director, New Ventures, Johnson & Johnson Innovation Center, Boston


Brad  Margus

Brad Margus
CEO, Exigence Neurosciences

Luciano  Marraffini

Luciano Marraffini
Assistant Professor and Head, Laboratory of Bacteriology, The Rockefeller University

Kim  McCleary

Kim McCleary
Director, Strategic Initiatives, FasterCures

Anna  McCollister-Slipp

Anna McCollister-Slipp
Co-Founder, Galileo Analytics

Michelle  McMurry-Heath

Michelle McMurry-Heath
Senior Director, Regulatory Strategy and Policy, FaegreBD Consulting

Beth  Meagher

Beth Meagher
Principal, Deloitte Consulting LLP

Michael  Milken

Michael Milken
Chairman, Milken Institute; Founder, FasterCures

Eric  Minikel

Eric Minikel
Co-Director, Prion Alliance

Mark  Murcko

Mark Murcko
Lecturer, Department of Biological Engineering, MIT; Senior Vice President of Strategy, Schrodinger; Principal, Disruptive Biomedical, LLC


Tom  Parsons

Tom Parsons
Co-Founder, HealthXL

Jean  Patel

Jean Patel
Deputy Director, Office of Antimicrobial Resistance, Centers for Disease Control and Prevention

Jit  Patel

Jit Patel
Vice President, Research Business Development, JDRF

Bray  Patrick-Lake

Bray Patrick-Lake
Director, Stakeholder Engagement, Clinical Trials Transformation Initiative

Ethan  Perlstein

Ethan Perlstein
Founder, Perlstein Lab PBC

Richard  Pops

Richard Pops
Chairman and CEO, Alkermes

Katherine  Priestley

Katherine Priestley
Managing Partner, Park Vale Capital


Kate  Rawson

Kate Rawson
Senior Editor, Prevision Policy LLC

Charlene  Reed

Charlene Reed
CEO, The Foundation to Combat Antimicrobial Resistance

Brock  Reeve

Brock Reeve
Executive Director, Harvard Stem Cell Institute; President, Poliwogg Regenerative Medicine Fund

John  Reites

John Reites
Senior Director, Health Engagement and Communications, Quintiles

Jessica  Richman

Jessica Richman
CEO, uBiome

Melinda  Richter

Melinda Richter
Head, Janssen Labs, Johnson & Johnson

Brian  Rosen

Brian Rosen
Chief Policy, Advocacy & Patient Access Officer, Leukemia & Lymphoma Society

Joseph  Ross

Joseph Ross
Assistant Professor, General Internal Medicine, Yale University School of Medicine


Tomasz  Sablinski

Tomasz Sablinski
CEO, Transparency Life Sciences

Aenor  Sawyer

Aenor Sawyer
Associate Director, Strategic Relations, Center for Digital Health Innovation; Director, Skeletal Health Service, University of California, San Francisco

Eric  Schadt

Eric Schadt
Director of the Icahn Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences, and the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine, Mount Sinai

Sean  Schantzen

Sean Schantzen
Co-Founder, Healthfundr

Benjamin  Seet

Benjamin Seet
Executive Director, Biomedical Research Council, A*STAR

Joe  Selby

Joe Selby
Executive Director, Patient-Centered Outcomes Research Institute

Ravi  Seshadri

Ravi Seshadri
Vice President, Technology, NantHealth

Todd  Sherer

Todd Sherer
CEO, The Michael J. Fox Foundation for Parkinson's Research

Ellen  Sigal

Ellen Sigal
Chair and Founder, Friends of Cancer Research

Jonathan  Simons

Jonathan Simons
President and CEO, Prostate Cancer Foundation

Reisa  Sperling

Reisa Sperling
Director, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital; Professor of Neurology, Harvard Medical School

Melissa  Stevens

Melissa Stevens
Deputy Executive Director, FasterCures


Rudolph  Tanzi

Rudolph Tanzi
Director, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease; Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School

Luke  Timmerman

Luke Timmerman
Biotechnology Journalist

Suzanne  Topalian

Suzanne Topalian
Professor of Surgery and Oncology, and Director, Melanoma Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University


The Honorable Fred  Upton

The Honorable Fred Upton
Chairman, Committee on Energy and Commerce, U.S. House of Representatives


Sonia  Vallabh

Sonia Vallabh
Co-Director, Prion Alliance; PhD program, Biological and Biomedical Sciences, Harvard Medical School


John  Walsh

John Walsh
President and CEO, Alpha-1 Foundation

Dan  Wattendorf

Dan Wattendorf
Program Manager, Biological Technologies Office, Defense Advanced Research Projects Agency

Katherine  Wilemon

Katherine Wilemon
Founder and CEO, FH Foundation

Anne  Wojcicki

Anne Wojcicki
Co-Founder and CEO, 23andMe